You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triumeq

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Austin (TRIUMEQ, DOVATO)

Completed
  • HIV Infections
  • Austin, Texas
    GSK Investigational Site
Sep 21, 2021

HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg

Completed
  • HIV-1-infection
  • abacavir, dolutegravir and lamivudine dispersible tablets
  • Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
  • Montréal, Quebec, Canada
    Altasciences
Mar 10, 2022

HIV Trial in Nijmegen (Triumeq, Triumeq crushed + breakfast, Triumeq crushed + drip feed)

Completed
  • HIV
  • Triumeq
  • +2 more
  • Nijmegen, Netherlands
    CRCN, Radboud University Medical Center
Dec 4, 2020

HIV Trial in Montreal (Switch to Triumeq, Adherence support + current ART)

Completed
  • HIV Infections
  • Switch to Triumeq
  • Adherence support + current ART
  • Montreal, Quebec, Canada
    Chronic Viral Illness Service
Sep 1, 2020

HIV Trial in Austin (Treatment A, Treatment B, Treatment C)

Completed
Has Results
  • HIV Infections
  • Treatment A
  • +5 more
  • Austin, Texas
    GSK Investigational Site
Nov 20, 2019

Amyotrophic Lateral Sclerosis Trial in Australia (Triumeq)

Completed
  • Amyotrophic Lateral Sclerosis
  • Triumeq
  • North Ryde, New South Wales, Australia
  • +3 more
Aug 20, 2019

HIV-1-infection Trial in Liège (Dolutegravir 50 MG)

Recruiting
  • HIV-1-infection
  • Dolutegravir 50 MG
  • Liège, Belgium
    Liège university hospital
Apr 27, 2022

Human Immunodeficiency Virus Trial in Dublin (dolutegravir/abacavir/lamivudine)

Unknown status
  • Human Immunodeficiency Virus
  • Dublin, Ireland
    Mater Misericordiae University Hospital
Apr 25, 2019

HIV Trial in Sevilla (Continue with triple therapy, Switch to DTG + 3TC, Switch to DRV/cobicistat + 3TC)

Completed
  • HIV Infections
  • Continue with triple therapy
  • +2 more
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Aug 27, 2021

HIV-1 Infection Trial in Worldwide (ABC/DTG/3TC, B/F/TAF, ABC/DTG/3TC Placebo)

Completed
Has Results
  • HIV-1 Infection
  • Birmingham, Alabama
  • +120 more
Feb 7, 2022

HIV-1 Infection Trial in Worldwide (ABC/DTG/3TC, B/F/TAF, ABC/DTG/3TC Placebo)

Completed
Has Results
  • HIV-1 Infection
  • Phoenix, Arizona
  • +93 more
Oct 22, 2020

HIV Trial in France (dolutegravir 50mg +abacavir 600mg +lamivudine 300mg, dolutegravir)

Terminated
  • HIV
  • dolutegravir 50mg +abacavir 600mg +lamivudine 300mg
  • dolutegravir
  • La Roche sur Yon, France
  • +8 more
Nov 8, 2018

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV Trial in London (Triumeq)

Completed
  • HIV
  • Triumeq
  • London, United Kingdom
    St Stephen's Centre, Chelsea & Westminster Hospital
Feb 27, 2018

HIV-DDI Trial in Orlando, Boston (Riociguat (Adempas, BAY 63-2521), ATRIPLA, COMPLERA)

Completed
  • HIV-DDI
  • Riociguat (Adempas, BAY 63-2521)
  • +5 more
  • Orlando, Florida
  • +1 more
Dec 5, 2017

Infection, Human Immunodeficiency Virus Trial in Los Angeles (Triumeq)

Unknown status
  • Infection, Human Immunodeficiency Virus
  • Triumeq
  • Los Angeles, California
    Mills Clinical Research
Sep 5, 2017

Infection, Human Immunodeficiency Virus Trial in Overland Park (DTG/ABC/3TC FDC DISPERSIBLE TABLET, EPZICOM (ABC/3TC), TIVICAY

Completed
  • Infection, Human Immunodeficiency Virus
  • DTG/ABC/3TC FDC DISPERSIBLE TABLET
  • +2 more
  • Overland Park, Kansas
    GSK Investigational Site
Aug 3, 2017